ELF5 modulates the estrogen receptor cistrome in breast cancer

Acquired resistance to endocrine therapy is responsible for half of the therapeutic failures in the treatment of breast cancer. Recent findings have implicated increased expression of the ETS transcription factor ELF5 as a potential modulator of estrogen action and driver of endocrine resistance, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Piggin, Catherine L., Roden, Daniel L., Law, Andrew M. K., Molloy, Mark P., Krisp, Christoph, Swarbrick, Alexander, Naylor, Matthew J., Kalyuga, Maria, Kaplan, Warren, Oakes, Samantha R., Gallego-Ortega, David, Clark, Susan J., Carroll, Jason S., Bartonicek, Nenad, Ormandy, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959601/
https://www.ncbi.nlm.nih.gov/pubmed/31895944
http://dx.doi.org/10.1371/journal.pgen.1008531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959601/
https://www.ncbi.nlm.nih.gov/pubmed/31895944
http://dx.doi.org/10.1371/journal.pgen.1008531

Ejemplares similares